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ABSTRACT
The process of using electroporation to introduce plasmid DNA into host cells is a
valuable molecular technique that is increasingly employed in labs worldwide.
Electroporators are generally small and relatively inexpensive, making them attractive
systems to use for a variety of purposes. Electroporation protocols are numerous in the
published literature and encompass all cell types, from prokaryotic bacterial cells to
eukaryotic human cells. The TargeTron Gene Knockout System by Sigma-Aldrich is an
affordable option for the electroporation of numerous bacterial species. However, its
use in Listeria monocytogenes has not been extensively characterized. Here we sought
to discuss the effectiveness of the TargeTron Gene Knockout System in transforming
Listeria monocytogenes via electroporation along with the challenges this process
presents.

We attempted to transfect Listeria monocytogenes with two plasmids
constructed through SigmaAldrich as part of the TargeTron Gene Knockout System,
pACD4K-C and pNL9164, both of which are designed to induce targeted deletion of
genes within the host genome. Electroporation was performed under varying
conditions, with voltages ranging from 200 to 1250V. Following shock, cells were grown
in blood agar or brain heart infusion media containing kanamycin. Pores were induced
in the cell wall prior to electroporation by incubating the bacteria in media containing
pencillin, ampicillin, or lysozyme. Results show no colonies on selective media postelectroporation for either plasmid across all conditions.
v
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CHAPTER 1

Introduction
The process of using electroporation to introduce plasmid DNA into host cells is
an increasingly employed method in labs worldwide. Electroporators are generally small
and relatively inexpensive, making them attractive systems to use for a variety of
purposes. Electroporation protocols are numerous in the published literature and
encompass all cell types, from prokaryotic bacterial cells to eukaryotic human cells.
While a significant number of bacterial species have been successfully
transformed using this method, the specific protocols for each species vary greatly. In
some cases, the bacteria can be difficult to transform. Commercial systems have been
developed by manufacturers in order to make the process of transforming bacterial cells
more accessible, streamlined, and readily available. The TargeTron Gene Knockout
System by Sigma-Aldrich is rapidly becoming a commonly used system for
electroporating cells and is an affordable option for smaller, less well-funded
laboratories.
In this thesis, I will discuss the methods involved in attempting to transform
Listeria monocytogenes via electroporation along with the challenges this process
presents. I will also assess the effectiveness of the TargeTron Gene Knockout System
and whether or not it is a viable option for labs planning on working with this particular
species.
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CHAPTER 2
Literature Review
Listeria monocytogenes, PrfA, and listeriolysin O
Listeria monocytogenes is an intracellular, food-borne pathogenic bacterium
responsible for the disease listeriosis. It is classified as Gram-positive, motile via flagella,
and facultatively anaerobic. L. monocytogenes is not always pathogenic, but possesses
inherent and initially inactive cellular properties, primarily the production of a
hemolysin called listeriolysin O, that render it virulent upon activation. Although
normally limited to gastroenteritis in healthy individuals, infection with pathogenic
Listeria monocytogenes can cause up to a 30% fatality rate in certain risk groups,
including immunocompromised patients such as those with AIDS, the elderly, or the
very young (10). In pregnant women, infection of the fetus is possible, leading to
potential abortion or stillbirth (20).
In its extracellular state, L. monocytogenes exists as a non-virulent saprophyte
and is seen primarily in soil rich with decaying vegetable and plant matter (20). Once
ingested by a susceptible host, the bacteria enter epithelial cells of the GI tract. From
there, they move to the liver or spleen via macrophages, where they rapidly reproduce
within the cytosol of infected cells. If not stopped by the host immune system, they then
migrate to the bloodstream causing systemic or central nervous system infections (20).
While antibiotics are capable of halting these processes, prolonged use can lead to
harmful side effects, such as weight loss and disruption of the normal microbiota of the
2

host. To combat this, researchers are now investigating the use of bacteriophages as a
safer alternative treatment. Promising results have been observed in mice, with no
negative effects from the phages being reported (35).
The ability of L. monocytogenes to infect and destroy host tissue is mediated by a
variety of pathways, genes, and receptors (10). However, a regulatory gene known as
PrfA has been shown to control most of the virulence factors in pathogenic forms of the
bacteria (12). PrfA is post-translationally regulated and becomes activated upon arrival
in the cell cytosol (55). Synthesis of PrfA-regulated proteins has been shown to occur
under various types of environmental stress, particularly heat stress, although changes
in pH, sugar availability, and carbon metabolism appear to play an important role in
activation as well (42). While the environmental conditions required to activate PrfA
translation are known, the molecular method of activation has not been fully
determined. Primary activation appears to occur via the binding of a small cofactor not
yet identified, although research suggests that it may be a negatively charged ligand due
to the overall positive charge found within the PrfA binding pocket (55).
The regulatory and transcriptional pathways leading to PrfA translation after
initial environmental stress and cofactor binding are also poorly understood. However,
recent research indicates metabolic pathways, such as the branch chain amino acid
(BCAA) and arginine pathways, may play an important role in the ability of L.
monocytogenes to replicate within the cell cytosol (31). One study in particular explored
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the relationship between the BCAA pathway and the expression of virulence genes,
indicating a positive correlation between the two (31).
Of the virulence factors controlled by PrfA activation, the production of
listeriolysin O (LLO) is arguably the most important. LLO is a cholesterol-dependent,
pore-forming toxin and is biochemically similar to other commonly studied bacteria
toxins such as streptolysin O and perfringolysin O (61). It is encoded by the hly gene
locus and is an essential component for virulence. It is only present once the bacteria
have successfully entered host cells, although the specifics of this environmentallydriven activation are still unknown. To date, only a theoretical model of the protein's
folding exists as no crystal structures have been resolved.
Listeriolysin O is secreted outside of the bacterium as a monomer, although it
initially begins as a 529 residue precursor protein before cleavage (61). Upon secretion,
LLO migrates to the wall of the phagosome of macrophages where it then blocks the
fusion of the phagosome to the lysosome, although the exact mechanism of this action
is not currently known (61). This effectively halts destruction of the bacteria allowing it
to escape into the cell cytosol. From here, the bacteria is able to replicate and continue
proliferation throughout the host (61).
During escape from the phagosome, listeriolysin O works in synergy with lipases
such as phospholipase PI-PLC. However, even in the absence of these lipases, the
bacteria can still escape from the vacuole using LLO alone (LLO REVIEW). In contrast, the
absence of listeriolysin O significantly stunts escape in most cell types. It is for this
4

reason that I chose to focus on this particular virulence factor and its connection to the
translational activator PrfA in my study.

Methods of Listeria monocytogenes mutagenesis
Due to lack of thorough information regarding the relationship between
metabolism and virulence and its potential to be an effective way of reducing the ability
of the bacteria to spread in host cells, further research into this aspect of the bacteria’s
cellular processes should be conducted. A simple method for exploring this possible
connection would be through targeted mutagenesis of the bacterial genome, a process
which has been successfully accomplished, but yet still remains somewhat difficult ,
complex, and many times, costly.
The use of electroporation to transform Listeria monocytogenes has been
described previously in a multitude of papers (3, 38, 46). However, the specifics of this
process vary widely depending on the particular strain, gene locus, and vector being
used. Many studies also report varying degrees of effectiveness of the transformation
themselves, not only between different techniques, but also between repeated
performance of the same protocol and process, even within an individual study. Due to
these variations, finding a singular consistently effective protocol is difficult.
Further review of the literature also indicates that the vast majority of successful
studies show a strong favoring of the allelic exchange method in lieu of more basic
5

electroporation procedures. This method also appears to yield a higher number of
successful transformants in comparison to other commonly used methods, in particular
that of standard electroporation using bare plasmids.
Another popular method for the transformation of Listeria monocytogenes is
through transduction via the use of listeriophages. This method, as described by Lauer
(2002), once again proves to be relatively successful as compared to more standard
electroporation procedures. Unfortunately, this method requires more equipment and
reagents, making it significantly more expensive and costly.
While allelic exchange and transfection both appear to be viable methods for
introducing plasmid constructs into Listeria monocytogenes, they are also complex, time
consuming, and expensive procedures to perform. Smaller university labs, particularly
those with limited research funding or support, often lack the necessary equipment
required to implement these methods. The simpler system involving transformations via
transposons is a much more realistic venture for a small setup. However, this technique
is much more difficult to perform successfully in Listeria monocytogenes.
In 2008, Monk et. al. conducted a review of the tools available to observe
genomic changes in L. monocytogenes using the transposon method previously
mentioned above. Their results were impressive and a large number of transformants
were successfully recovered. However, like most transfection and allelic exchange
protocols, the methods used to design the Listeria -specific plasmids used in the study
were complex, expensive, and difficult to perform. Required reagents included a total of
6

six different vector constructs, 10 sets of primers, a strain of E. coli, and eggs obtained
from the frog species X. laevis for cytoplasmic culture (35, 38). Unfortunately, this level
of vector construction is generally beyond the scope of a smaller lab. Due to these
limitations, a simpler and more user-friendly system is desirable.

The TargeTron Gene Knockout System
The TargeTron Gene Knockout System is a simple and streamlined protocol
designed by Sigma-Aldrich for the purpose of rapidly and permanently interrupting
genes in a variety of prokaryotic organisms (50). The system was primarily designed with
E. coli and other taxonomically related bacteria in mind; however, the availability of
different TargeTron vectors allows the system to be used in a wide variety of bacteria
(50). It has been tested in numerous bacterial species, both Gram-positive and Gramnegative, including S. aureus, S. pyogenes, and E. coli.
It is important to note that the TargeTron System protocol is geared toward the
design of primers, ligation of plasmids, and the induction of introns present within the
available vectors. While it is intended to be used as a way of introducing transposable
elements into the genome of cells through the use of electroporation, it does not
actually include the specific parameters needed to accomplish this. Instead, the system
requires users to find appropriate information using outside resources.
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While the efficiency of the TargeTron System has been clearly demonstrated
across numerous genera, Listeria does not fall under this category. As it stands, only one
independent study, (3), has successfully recovered transformants using this system. The
study, which was conducted to assess the effect of mutational activation of PrsA2 on the
virulence of the bacteria, used the pNL9164 vector alongside a separate, cadmiuminducible shuttle vector (3). This additional shuttle vector is not an official TargeTron
vector and is not commercially available for purchase.

Proposed Project
For my project, I attempted to fill in some of the gaps in knowledge indicated by
previous research. As stated earlier, prior studies have suggested that the cellular
processes governing metabolism may be connected to those controlling virulence
activation (31). Based on this, I designed my project to examine at the effect of
interrupting the arginine tRNA ligase gene on production of listeriolysin O. A decision
was made to use the TargeTron Gene Knockout System by Sigma-Aldrich to complete
this study as our lab was already in possession of the written protocol, all standard
reagents required, and an adequate amount of complementary primer purchases.
However, after a considerable amount of time attempting to complete our designed
project, it became apparent that the system chosen was not producing results. At this
point, my research focus shifted from the effects of transformation to the technical
8

process of Listeria monocytogenes mutagenesis itself. Multiple published studies show
that this process is incredibly complex and nuanced with consistent results being
somewhat tenuous (38). Only one paper, published by Alonzo in 2009, addresses the
TargeTron System’s use in this particular species of bacteria. For this reason, I chose to
aim this thesis at the overall efficiency of the TargeTron System and its associated
vectors and reagents in transforming Listeria monocytogenes and whether or not it is a
viable option for smaller labs such as ours.
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Glossary of Terms
Arginine tRNA ligase - a gene involved in the metabolism and synthesis of arginine
Electrocompetence - a state in which cells are prepared to undergo electroporation;
involves specific growth parameters, media, and treatment with antibiotics
Electroporation - the use of an electrical voltage to create small pores in the wall of cells
in order to allow the uptake of plasmid DNA
Listeria monocytogenes - a pathogenic bacterial species responsible for listeriosis
Listeriolysin O - a hemolysin used by L. monocytogenes primarily to escape host cell
vacuoles
PrfA - a gene that controls a significant amount of virulence factors present in L.
monocytogenes
Saprophyte - an organism that feeds on decaying organic matter

10

Purpose of Research
For this project, our lab attempted to fill in some of the gaps previous research has
indicated. As stated earlier, prior studies have suggested that the cellular processes
governing metabolism may be connected to those controlling virulence activation.
Based on this, I designed my project to look at the effect of interrupting the arginine
tRNA ligase gene on listeriolysin O production. A decision was made to use the
TargeTron Gene Knockout System by Sigma-Aldrich to complete this study as our lab
was already in possession of the written protocol, all standard reagents required, and an
adequate amount of complementary primer purchases.
As transformation of Listeria was not possible, we shifted focus onto the viability
of the TargeTron Gene Knockout System itself. Thus, this thesis serves as an attempt to
document the pitfalls and complications involved with using this system as a
mutagenesis protocol for the transformation of Listeria monocytogenes.
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CHAPTER 3
Methods
Listeria monocytogenes strain
For this project, we chose the L. monocytogenes strain EGD-e (Murray, et. al.)
purchased from ATCC®. Kwik-Stick swabs were kept at 4° C prior to culturing. Bacteria was
cultured on blood agar plates (BAP) using isolation streaking and incubated overnight in
a 37° C table-top incubator. Individual colonies were subsequently harvested and
transferred to sterile Eppendorf tubes containing 1mL of fresh 1% serum sorbitol solution
(100 mL distilled water, 1g sorbitol, 1mL bovine solution, mixed and autoclaved. Tubes
were stored at -80° C until needed. In total, 15 tubes were prepared and frozen.

Primer design for arginine tRNA-ligase
To locate the insertion site for gene interruption, we used the NCBI GenBank
program to choose an appropriate gene locus. The locus containing the arginine tRNAligase gene (Accession #YP_007608457) was determined to be the best choice. To
design primers for re-targeting of the vector, we used the TargeTron Gene Knockout
System automated algorithm. Three sites were generated using this system and ranked
according to the estimated percentage of insertion success. The top two matches were
chosen for this study. Primers were generated via the TargeTron System.
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Testing of DNA extraction protocols for detection of listeriolysin O in samples
Prior to beginning the mutagenesis protocol, we tested the efficiency of the
Invitrogen DNA extraction kit in isolating DNA from Listeria monocytogenes. Thawed
samples were cultured on BAP and incubated at 37° C overnight. Individual colonies were
then transferred to tubes containing 9mL of tryptic soy broth (TSB) and again incubated
overnight at 37° C. DNA was extracted from the broth cultures using the protocol included
with the Invitrogen DNA extraction kit. DNA was extracted via ethanol precipitation. The
resuspended DNA pellet was kept in sterile Eppendorf tubes at 4° C overnight or -25° C
for long-term storage. Thawed samples of DNA were tested for amount and purity using
the NanoDrop™ provided by another lab.

Testing of positive controls for detection of listeriolysin O through PCR
Upon receiving the Invitrogen primers specific to the gene locus hly (accession
#NC_003210.1), we tested our previously cultured samples for the presence of
listeriolysin O in order to confirm our positive controls. Samples of frozen culture were
thawed and mixed thoroughly. Each primer was rehydrated with 11.95 µL of RNase free
water to make 12 µL of master stock. Rehydrated primers were then further diluted into
working stock (10 µl master stock, 90 µl RNase free water) and aliquoted into sterile PCR
tubes for storage at 4° C.

13

Samples from the previous DNA extraction with high yields were chosen for
positive controls. A total of 4 tubes were prepared. Upon completion of PCR, samples
were removed and analyzed via gel electrophoresis using a 1% agar gel with a run time of
1.5 hours at 80 V. The gel was then observed under UV light for bands at 48 kDa.

Primer-mediated re-targeting of TargeTron System introns via PCR and gel electrophoresis
Two primer sets specific for the arginine tRNA gene locus acquired via the
TargeTron System were rehydrated to 100 µM in preparation of PCR (designated 285285a IBS, EBS1d, EBS2 and 97-97a IBS, EBS1d, and EBS2). A master mix was prepared for
each set according to the TageTron Gene Knockout System protocol guidelines for a total
of 20 µl (Fig 1). PCR reactions were prepared using GE Healthcare PuReTaq tubes (23 µl
RNase free water, 1 µl master mix, 1 µl intron PCR template, and 25 µl JumpStart REDTaq
ReadyMix). After PCR cycling was complete, 3 µl of loading dye and 7 µl of water were
added to 10 µl of the PCR samples and mixed thoroughly. Samples were then loaded into
a 1% agar gel and run using a standard gel electrophoresis protocol. The gels were
observed under UV light for the presence of banding at 300 bp.
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Purification of PCR products
PCR products were purified with the GenElute PCR Purification kit from SigmaAldrich using the protocol provided. A ratio of 50 µl of binding buffer to 10 µl of PCR
product was determined to be optimal. Purified products were then tested via the
NanoDrop machine as described previously. Gel electrophoresis was performed on
purified samples to ensure an increase in purity and adequate yield.

Double digestion of purified PCR products
Samples were digested according to the TargeTron System protocol. 8 µl of
purified PCR product, 2 µl of 10x Restriction Enzyme Buffer, 1 µl of the restriction enzyme
HindIII, 1 µl of the restriction enzyme BsrGI, and 8 µl of RNase free water were added to
an Eppendorf tube and vortexed. Tubes were incubated in a 37° C water bath for 30
minutes, a 60° C water bath for 30 minutes, and an 80° C water bath for 10 minutes. After
cooling, samples were then stored at
-20° C overnight.

Preparation of media for electroporation protocol
Brain heart infusion (BHI) broth was prepared using 74 g of powdered BHI per 1
litre distilled water. The mixture was stirred and heated till boiling to ensure complete
15

homogeneity of solution and subsequently autoclaved for sterilization. A sucrose solution
containing 59.9 g of sucrose in 175 mL of distilled water was made for supplementation
of BHI broth. The mixture was stirred and heated until all sucrose had dissolved and
subsequently filter sterilized into a freshly autoclaved flask using a .45 micron nylon
membrane syringe filter. BHI sucrose (BHIS) broth was prepared by mixing BHI broth and
sucrose solutions in a 1:1 ratio.
Selective media was prepared by supplementing 500 mL autoclaved BHI agar with
450 µl stock kanamycin solution. Plates were stored in the walk-in freezer at 4° C until
needed.

Preparation of electrocompetent cells
Thawed L.monocytogenes was cultured on BAP overnight at 37° C. Individual
colonies were subcultured in 7.5 mL BHI broth supplemented with 7.5 mL filtered sucrose
solution overnight at 37° C. The following day, 5 mL of subculture was transferred into 50
mL of BHIS and incubated for 4 hours at 37° C. At 4 hours, 1 mL of penicillin G stock
solution (0.0125 g penicillin sodium salt + 20 mL NaOH) was added to the BHIS broth and
incubation continued for a further 2.5 hrs.
The bacterial culture was then transferred to a sterile, disposable centrifuge tube.
The solution was centrifuged at 5000 x g, 4° C for 10 minutes. Supernatant was removed
and the cells washed with 40 mL of filtered sucrose solution. The tube was again
16

centrifuged using the same parameters. Supernatant was removed and cells washed with
20 mL of sucrose solution. This was repeated twice. After the final spin, supernatant was
removed and the cells were resuspended in 2.5 mL of sucrose solution. 100 µl aliquots
were transferred into sterile autoclaved Eppendorf tubes and frozen at -25° C until further
use.

Ligation of TargeTron System vector
In accordance with the TargeTron System protocol provided in the kit, the
TargeTron vector pACD4K-C was ligated using the QuickLink T4 Ligation Kit (Sigma-Aldrich,
cat. #LIG2-1KT). A solution containing 2 µl vector, 6 µl digested primer product as
previously described, 10 µl QuickLink Buffer A, and 2 µl QuickLink Buffer B was prepared
and mixed in a sterile Eppendorf tube. The mixture was heated to 60° C via water bath for
30 seconds. The tube was then immediately transferred to ice and cooled for 1 minute.
Upon removal from ice, 1 µl of QuickLink T4 Ligase was added to the mixture. The tube
was left at room temperature for 30 minutes.

Transformation of Listeria monocytogenes
After ligation, 100 µl of thawed electrocompetent cells were transferred into a
chilled 1 mm Bio-Rad cuvette. The entirety of the ligation mixture (a total of 20 µl) was
added to the cuvette. The cuvette was loaded into the Bio-Rad GenePulser Xcell
17

electroporator. Cells were pulsed in the electroporator at 1,250 volts (V), 25 mirco farads
(µF), and 200 Ohm. This protocol was based off of recommended settings in the user
manual for the TargeTron System.
Electroporated samples incubated for 1.5 hrs in a low temperature incubator at
30° C. Upon removal from the incubator, the samples were plated on BAP and
BHI+kanamycin media and incubated overnight at 37° C.

Substitution of provided vector with pNL9164
Due to the lack of results, each subsequent transformation attempt was modified
in an attempt to confer a higher rate of plasmid uptake and integration. The vector
pACD4K-C was replaced with another TargeTron vector (pNL9164, Sigma-Aldrich, Cat.
#T6701-2UG), a Gram positive specific vector that had been reported to be successful
according to previous research (3).
This substitution required a minor change in the previously reported digestion
protocol and is described as follows: 1 µl of the restriction enzyme DpnI was added while
the given amount of distilled water was reduced from 8 µl to 7 µl. This resulted in a slightly
modified digestion mixture with the total volume remaining 20 µl.
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Table 1. Attempted Modifications to the TargeTron System Protocol. (*represents inclusion of lysozyme.)

Growth
Electroporation Inc.
Plate
Media Antibiotic Plasmid Wash Buffer Cells
Parameters Time Media Colonies
1 mL
penicillin
250 mL
G stock
BHI +
(0.0125
1250 V, 25 µF,
BAP, LB +
sucrose g/20 mL) pACD4K-C Sucrose Thawed 200 Ohms 2 hrs
kan
None
2.5 mL
penicillin
250 mL
G stock
BHI +
(100
1000 V, 25 µF,
BAP, LB +
sucrose mg/mL) pACD4K-C Sucrose Thawed 200 Ohms
1 hr
kan
None
5 mL
100 mL penicillin
BHI + G stock (1
1000 V, 25 µF,
BAP, LB +
sucrose mg/mL) pACD4K-C Sucrose Thawed 200 Ohms
1 hr
kan
None
100 µl
*500 mL ampicillin
BHIS
stock (50
1000 V, 25 µF, 1.5 BAP, BHI +
autoclaved mg/mL) pACD4K-C SGWB Thawed 400 Ohms
hrs
kan BAP only
10 µl
*50 mL ampicillin
BHIS
stock (50
1000 V, 25 µF, 20 BAP, BHI +
autoclaved mg/mL) pACD4K-C SGWB Thawed 400 Ohms
min
kan BAP only
10 µl
ampicillin
stock (50
mg/mL) +
*50 mL 10 µl
BHIS kanamycin
200 V, 25 µF, 20 BAP, BHI +
autoclaved stock
pNL9164
SGWB Thawed 400 Ohms
min
kan
None
10 µl
ampicillin
BAP and
50 mL BHIS stock (50
1000 V, 25 µF, 1.5 BAP, BHI + BHI +
autoclaved mg/mL) pNL9164
SGWB Thawed 400 Ohms
hrs
kan
kan*
10 µl
ampicillin
BAP,
50 mL BHIS stock (50
500V, 25 µF, 1.5 BHI + kan,
autoclaved mg/mL) pACD4K-C Sucrose Thawed 400 Ohms
hrs LB + kan BAP only
10 µl
ampicillin
BAP,
50 mL BHIS stock (50
750 V, 25 µF, 1.5 BHI + kan,
autoclaved mg/mL) pNL9164
BHI
Fresh
400 Ohms
hrs LB + kan BAP only
19

Other changes to standard protocol
In addition to the substitution of pACD4K-C with pNL9164, other modifications
were made to each attempted transformation. Due to the high number of attempted
transformations, all modifications made are categorized in the table on the following page
(Table 1).
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CHAPTER 4
Results
Gel electrophoresis of positive controls and re-targeted TargeTron primers
Positive control samples amplified at the hly gene locus showed banding at
approximately 250 bp (Fig 2). This is consistent with expected results of the
electrophoresis, with the amplified portion of the hly gene being approximately 200-300
bp in size (29).

Fig 1. Gel Electrophoresis of Positive Controls
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Re-targeted primers showed clear, bright banding at 300 bp (Fig 3). This is
consistent with predicted results according to the TargeTron System protocol (50).

Fig 2. Gel Electrophoresis of Re-Targeted TargeTron Primers

Purified re-targeted primers also showed banding at 300 bp as expected (Fig 4).
However, one of our primer sets (95-96, shown in wells 4 and 5 in the figure below) did
not stay in their designated wells. Two new samples were mixed with loading dye and
re-entered before running the gel.
22

Fig 3. Gel Electrophoresis of Purified Re-Targeted TargeTron Primers

Electrocompetent cell growth and transformations
Multiple attempts to transform Listeria monocytogenes proved unsuccessful
using the provided reagents, protocols, and vectors that were included with the
TargeTron System. Modifications to the protocols compiled from outside sources were
implemented with varying results (Table 1). Some changes, in particular the transition
from a sucrose wash buffer to SGWB (without the addition of lysozyme), dramatically
23

increased growth of electroporated cells on BAP. When using only the sucrose solution,
few colonies were seen on the plates with most concentrated in the area of the primary
streak. Upon switching to SGWB, complete growth comprising all streaked segments of
plate were observed. When supplementing the SGWB with lysozyme according to the
protocol put forth by Park, growth was significantly hindered, although still more
pronounced than that seen using only sucrose.
Growth of transformed bacteria on selective media appeared to be virtually
nonexistent. A small amount of growth was observed after run #7 on the selective
media BHI+kanamycin (indicated in Table 1 by the asterisk), but upon performing a
Gram stain, these colonies were shown to be Staphylococcus epidermidis. We concluded
that this was due to contamination of the sample tubes prior to electroporation. This
resulted in viable S. epidermis cells taking up the pNL9164 ligated vector present in the
cuvette during electroporation. These results are consistent with the advertised use of
the vector, which is described as species-specific for Staphylococcus and more generally
for all Gram positive species as a whole.
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CHAPTER 5
Discussion
First Hypothesis
Upon beginning our originally planned project, our goal had been to introduce a
mutation in the arginine-tRNA ligase gene locus of the L. monocytogenes genome. This
gene was chosen based on its involvement with the bacterial metabolism of this species,
specifically in the catabolism of environmental arginine. As previous studies had shown a
possible link between active metabolism genes and the synthesis of virulence factors, we
believed that a connection could exist between certain metabolic genes and the
production of listeriolysin O, a highly important hemolysin required for the pathogenesis
of the bacterium (31).
Originally, our proposed outline had included multiple metabolic genes, including
pyridoxine kinase and the thiT thiamine transporter gene (45). However, exploring these
other genes was contingent upon successful transformation of L. monocytogenes through
the mutation of arginine-tRNA ligase.
It is important to note here that the gene for arginine-tRNA ligase, which is a
critical element of the translation machinery, is vital in regard to protein synthesis and
cellular function. In many instances, this gene could very easily be considered to be
essential to the cellular function of the bacterium. However, due to the discussion of
arginine biosynthesis potentially being involved in activation of PrfA-mediated virulence
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in the paper by Lobel, et. al., we proceeded with mutagenesis attempts under the
assumption that this paricular gene was non-essential in L. monocytogenes. This
assumption could very well be erroneous and is discussed in the section titled
"PROBLEMS, TROUBLESHOOTING, AND IMPROVEMENTS."

Protocol Selection
As stated in the introduction of this thesis, we chose the TargeTron Gene
Knockout System as our protocol for a variety of reasons, including the availability of
reagents, the accessibility with which the user manual was designed, and primers
included with the kit. In addition, on-going experiments conducted by other students in
the lab had led to numerous successful transformations and plasmid integrations in
multiple different species. This led us to believe that it could potentially be a viable and
useful method of introducing mutations in Listeria monocytogenes as well.
For the preparation of electrocompetent cells, a simple protocol titled
"Transformation of Listeria monocytogenes" was obtained via an online database of
user-submitted protocols (51). Adjustments to volume were made to accommodate a
smaller lab size, although ratios of reagents, antibiotics, and live culture remained the
same, as did incubation times and temperatures.
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Initial Transformation Attempts
Repeated attempts were made to transform our samples using the protocol
cited above (51). It is assumed that these transformations all failed, as no growth was
observed on any of the plates. Gel electrophoresis results indicated that the plasmids
were being properly retargeted to our gene of interest through PCR (Fig. 3 and 4).
However, as these PCR products were never sequenced, it is possible that the bands
were indistinguishable from those of non-retargeted plasmid. Arginine-tRNA ligase is
known to be a very small gene of only about 300 bp. On a gel with a ladder for
constructs upwards of 7,000 bp, this is an incredibly incremental size difference that
would lead to very similar bands. If this were the case, it could easily be attributed to
simple human error and a lack of appropriate controls, issues which will be discussed
further in the section "PROBLEMS, TROUBLESHOOTING, AND IMPROVEMENTS."
In theory, however, an improperly targeted plasmid should not necessarily lead
to a lack of growth on media provided it did not disrupt additional genes required for L.
monocytogenes' survival in vitro. In general, un-incorporated, empty vector is relatively
harmless to bacteria and is often lost during subsequent replication. If an empty vector
containing an antibiotic resistance gene were to remain within a population of bacteria,
growth on selective media should be observable. For this reason, I believe that an
unsuitable or harmful empty plasmid would not be a viable explanation for the lack of
transformants recovered during these initial attempts.
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Revision of Protocols
After repeated attempts to transform our samples using the initial protocols we
had chosen failed, we began to make modifications to both the TargeTron System as well
as our preparation of cells prior to electroporation. We abandoned the online protocol
that outlined electrocompetency in lieu of a more thorough and peer-reviewed system
by Monk (2008). This new protocol made significant changes to both the antibiotics used
and the media used to grow our cultures (39). However, while this change significantly
improved the viability of our cells after electroporation and led to increased growth on
our non-selective BAP media, it did not contribute to the recovery of transformed cells on
our selective media.
After calling Sigma-Aldrich and speaking with a consultant, we were informed of a
paper by Alonzo that used the TargeTron Gene Knockout System to transform Listeria
monocytogenes (3). As of now, this paper appears to be the only published example of
this system successfully inducing observable mutations through this system within this
particular species of bacteria. As opposed to using the standard pACD4k-C linear vector
provided in the base TargeTron System kit, this study used the TargeTron vector pNL9164,
which has been optimized for Gram-positive bacteria (3).
A comparison of the two vectors shows significant differences including the type
of selective resistance markers, promotors, origin of replications, and size of the construct
itself (Fig 5). Any of these changes could potentially modify the behavior of the plasmid
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once integrated into the bacterium. For example, one promoter could be more powerful,
leading to a higher replication rate.
Using this new vector alongside the modifications in our electrocompetency
protocol,

we

again

attempted

to

transform

our

samples

(see

Problems,

Troubleshooting...). Additional failed attempts led to more modifications to our previous
protocol all to no avail. A final modification was considered involving the use of a different
vector entirely unrelated to the TargeTron System. As stated previously in the literature
review, there exists a wide variety of options for performing mutagenesis in L.
monocytogenes using allelic exchange, horizontal gene transfer via conjugation, and
transduction through the use of listeriophages (30, 38, 40). However, very few papers
focus on transformations using bare plasmid as was being performed in this study. Those
that did choose this method used very complex plasmids constructed from the ground
up, targeted and designed to integrated only within their specific gene of interest. An
example of this type of system can be seen in Lyska (2013) where researchers used a
multitude of oligonucleotides and promoters to build a working vector series for their
species of interest. This procedure started with a commercial vector which was then
modified via PCR and ligation multiple times to reach a viable construct.
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Fig 4. Comparison of pNL9164 and pACD4K-C. Source: "TargeTron Gene Knockout System User Guide."
Sigma Aldrich, 2008.

Unfortunately, manufacturing this type of plasmid is incredibly complicated,
costly, and time consuming. Additionally, designing the final, usable vector requires a
starting base construct with its own set of requirements that are equally as complex (35,
38). For a smaller lab, constructing these plasmids with the available resources is
unrealistic, especially in the event of a closing deadline, as was the case in our study.
Attempts were made to contact a private company in the event that they could construct
the vector for us, but their own reservations about the complexity of the project
eliminated the possibility of receiving the vector in a timely manner. Due to increasing
time constraints and the inability to find a supplier of our preferred plasmid, a decision

30

was made to reframe our original hypothesis rather than continuing to make
modifications to our transformation protocol.

Final Hypothesis
In light of our unsuccessful attempts at transforming Listeria monocytogenes, we
decided to alter our focus from the virulence, metabolism, and genetics of the bacterium
to the techniques and available systems used to generate mutations in this particular
species. As stated earlier, only one paper has been published on the use of the TargeTron
Gene Knockout System in Listeria monocytogenes. This paper (3) was successful in its
attempt to transform the bacteria, but showed a lack of efficiency and a lower yield than
that of other studies using different methods. As no other papers attempting to replicate
these results were discovered, we have decided to explore the data, modifications, and
results collected in this thesis to discover whether or not the TargeTron Gene Knockout
System and its available vectors is a viable method for the transforming Listeria
monocytogenes in a small laboratory setting.

Assessment of protocols, vectors, and the TargeTron Gene Knockout System
In this particular study, we used multiple types of antibiotic treatment to
introduce the previously described pores. Specifically, we chose penicillin G and
ampicillin. This selection was chosen based on prior research which referenced these
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antibiotics on multiple occasions (3, 38). Stock solutions created with these antibiotics
were roughly 10 mg/mL in concentration. While it is possible that the amount of
antibiotic used during incubation could have negatively affected the survival rate of our
samples, repeated growth of the samples on BAP indicate that this is unlikely.
Electroporation parameters were also chosen based on those described in prior
research with modifications implemented after multiple failed attempts. Once again, it
is unlikely that these changes, specifically the increase in voltage to 1500V or the
extended duration of pulses, contributed to the lack of growth on selective media due
to the repeated growth on BAP that occurred with most samples that were shocked.
Having eliminated other explanations, we concluded that the lack of successful
transformants could only be explained by the inability of our ligated plasmids to enter
the cells. There are two points at which this failure could be occurring: entry of the
vector into the host cell or integration of the ligated plasmid into the genome of the
bacteria.
The inability of the vector to be taken up by the bacteria could be caused by an
insufficient breakdown of the cell wall prior to electroporation. When using a standard
transformation protocol in which the bacteria is incubated with bare plasmid DNA, it is
crucial that the cells be properly prepared beforehand. Broadly, this requires a
temporary and repairable disintegration of small areas of cell wall large enough to allow
entry of the plasmid yet small enough to not cause cell lysis. This process tends to be
more difficult in Gram-positive bacteria due to the thick peptidoglycan layer present.
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Many Listeria species also possess the ability to produce a capsule which could
potentially further complicate the induction of these pores, although these capsules are
rarely observed in controlled laboratory environments and may be negligible in their
effect.
Provided that the plasmid is able to successfully enter cells, it must then
integrate into the host genome. It is at this point that the re-targeting accomplished by
the TargeTron Gene Knockout System becomes particularly important. If the intron has
been re-targeted appropriately, the plasmid should easily insert into the gene of
interest; however, if the plasmid was not properly targeted, it will remain in the cytosol
of the cell where it is vulnerable to disintegration or migration out of the cell itself.
It is difficult to confirm at which point in the process our system was
experiencing difficulty. The lack of growth on our BHI+kanamycin and BHI+ampicillin
plates indicate that there were no viable transformants generated by our
electroporation, but it does not indicate whether or not the cells initially received the
vector. As the TargeTron System plasmids require successful integration for activation of
their resistance genes, potential vectors free-floating in the cells could confer growth on
selective media, making it impossible to distinguish between cells with intake plasmids
versus those without. However, as plasmids are prone to being lost after multiple
cellular divisions and as numerous different electrocompetency protocols were
attempted, we have concluded that the most likely explanation is the inability of the
generalized TargeTron System plasmids to properly integrate into the host cell genome
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as compared to plasmids designed and specifically constructed for Listeria
monocytogenes.
In conclusion, these consistently negative results suggest that while the
TargeTron Gene Knockout System is a simple, user-friendly, and affordable system for
many other bacterial species, the limited vectors and lack of sufficient trials in Listeria
species' make it a poor choice for the transformation of Listeria monocytogenes.

Problems, Troubleshooting, and Improvements
The first write-up of the results and discussion sections reported in this thesis
were compiled in August, 2014. A detailed review of these initial findings in the
following months showed a significant number of issues, mistakes, and unaddressed
potential solutions within the methods used to conduct these experiments. This section
will attempt to address some of these mistakes as well as provide improvements that
could have been implemented.

TargeTron System Plasmid Re-Targeting
As stated earlier in the discussion section, it is possible that the pACD4K-C
plasmid I was attempting to retarget for our gene of interest was not correct and was
instead empty, non-specific vector. While the bands observed on my electrophoresis
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gels appeared to be in the correct spot, this does not guarantee a correct plasmid. Gel
electrophoresis is a quick, easy, and useful method for determining the relative size of
PCR products but is not an absolute indicator of plasmid size, sequence, or target. As the
gene of interest for this study is incredibly small (~300 bp), the difference between a
plasmid size of approximately 7,700 bp and 8,000 bp is almost impossible to distinguish
using a gel alone. In hindsight, relying on this method for retargeting my plasmid was,
frankly, naive and ineffective. However, had additional steps been taken alongside the
electrophoresis, the technique might have been much more reliable
The easiest way to improve upon this method for differentiating retargeted
plasmid from empty plasmid would be to simply run empty vector alongside ligated
vector in the same gel as a control. While the differences between the two would be
very small, seeing them both side by side on the same gel could have shown an
observable size shift between bands. If this size shift was large enough to be seen by the
naked eye, it could indicate that the plasmid had been altered to incorporate the
targeted section specific for our gene of interest. This size shift would not have given
any additional details such as direction of the targeted section or the plasmid's
sequence, but it would be an essential first step in determining if our retargeting
protocol was working effectively.
In addition to this simple electrophoresis control, sending off the samples for
sequencing would be the best way to ensure that the plasmid was not only re-targeted
to our gene of interest, but also oriented properly. Orientation of the variable region of
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a plasmid can play an important role in the function of said plasmid. Improperly
oriented variable regions can place promoter regions in inappropriate directions,
leading to no transcription of the genes under their control. Misplaced promoter regions
can also lead to an increase in transcription of potentially dangerous genes or a
decrease in genes which are essential, both of which could adversely affect the survival
rate of the transformed bacteria.

Media Preparation and Inappropriate Antibiotic Choice
When preparing selective media for recovery of transformed bacteria, use of a
proper antibiotic is essential. The two plasmids used in this study, pACD4K-C and
pNL9164, have resistance genes for ampicillin and kanamycin, respectively.
Unfortunately, the selective media used to plate the bacteria after it had been
electroporated with these plasmids did not always contain appropriately matching
antibiotics.
During the first half of the study, I attempted to transform Listeria
monocytogenes with the pACD4K-C. However, instead of using ampicillin in my BHI
plates, I used kanamycin. The reason for this is unknown, even after consulting the lab
notebook associated with these experiments. In lieu of a specific, documented reason
for this choice, it is my assumption that it was a mistake due to either a lack of
understanding of the plasmid itself or a mix-up between the two plasmids. Use of an
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inappropriate antibiotic would have been crippling to the study, as even properly
transformed bacteria that had integrated plasmid present would not have been able to
grow on antibiotic plates without the associated resistance gene.
During the second half of the study, I continued to use kanamycin plates while
also using the pNL9164 plasmid in my transformations. However, even though this
antibiotic and the resistance gene present in the plasmid are complimentary to one
another, I still saw no growth on my selective media. Considering that the pNL9164
plasmid was designed specifically for Gram-positive bacteria and that I was seeing
substantial improvements in growth on my non-selective media, it seems unlikely that
the major issues in this study can all be attributed to using the wrong antibiotic plates
while attempting to transform the bacteria with pACD4K-C. There is a small chance that
the initial transformation attempts with the pACD4K-C plasmid were actually effective
and simply not being recovered due to my mistake, but I feel that this is unlikely simply
because proper transformations with pNL9164 should have been more effective than
those performed with pACD4K-C due to its specificity for Gram-positive bacteria.

Arginine t-RNA Ligase
The most glaring issue of this thesis is the target gene itself. A survey of the
literature lead me to a paper that provided a brief list of metabolic targets whose
relationships with the regulatory PrfA gene needed further characterization. Mentioned
in this list was the gene encoding arginine tRNA ligase. At the time, my knowledge and
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understanding of metabolism, genetic replication, and vector-mediated knockouts was
minimal. Due to my lack of thorough understanding of arginine tRNA ligase’s function, I
chose to begin with this particular gene.
However, months later, after beginning my Ph.D. study and taking more in-depth
classes on genetics and cellular metabolism, I realized that choosing to knockout a gene
that codes for a tRNA ligase was an incredibly poor choice. During DNA replication, the
various tRNAs are responsible for locating appropriate amino acids to the replication
machinery during translation. tRNA ligase is then facilitates binding of the amino acid to
the synthesizing strand of DNA that is being produced during translation.
Arginine, an amino acid that is present in numerous, if not nearly all, proteins is
required for proper function of cellular mechanisms. By knocking out the ligase that
allows this amino acid to attach to replicating DNA, we would effectively halt translation
of potentially essential proteins, or, adversely affect their ability to properly fold due to
changing the hydrophobicity or charge present in their domains. In the event that these
proteins were not able to be synthesized properly or be folded into their normal
confirmation, we could very easily have induced lethal cellular defects or halted growth
and replication of the bacteria.
From this line of thought, we can assume that in the event of our plasmid being
successfully been retargeted and inserted into the genome of Listeria monocytogenes,
disruption or knockout of the arginine tRNA ligase could have attributed to the lack of
growth seen on both our selective and non-selective media. While we did observe small
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amounts of growth on non-selective BAP plates after some electroporation attempts, it
is more likely that the colonies found were simply bacteria that did not pick up the
plasmid due to the lack of growth on selective media from these same attempts.
However, ideally, when growth is observed on non-selective media, the next
step would be to plasmid purify the colony through performing a mini-prep, plasmid
extraction, and gel electrophoresis and clean-up. The DNA could then be sent off for
sequencing using primers that specific to our insertion site in an attempt to confirm that
the plasmid was present. Unfortunately, due to my own inexperience and lack of
confidence in these positive results, this step was never taken.
Nevertheless, I still believe that the poor choice of target gene is the most likely
explanation for our lack of results as an inappropriately targeted plasmid or one that
was unable to cross the cell wall into the cytoplasm of the bacterium would likely not
halt all growth on non-selective media. Instead, we would most likely find colonies
lacking plasmid entirely or containing empty or inactive vector.

Future research
While these results indicate that the TargeTron System should be avoided in lieu
of more complex methods when attempting to induce mutations into this particular
species, it does not mean that it could not eventually become an effective system with
the proper modifications made. Due to the vast number of mistakes and potentially
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incorrect assumptions made during the course of this study, the results presented
should not be taken as reliable. In addition, as stated previously in the literature review,
Alonzo, et. al., successfully used this system to introduce genetic deletions in Listeria
monocytogenes, suggesting that with the proper vectors and parameters, the TargeTron
protocol could still be a viable method of transformation. If this were the case, it would
be especially helpful for smaller labs where access to expensive constructs and
equipment is not readily available.
However, in light of this study, it may be more applicable to use alternative
methods for silencing or deleting genes of interest that do include electroporation of
this bacteria. One such method that could prove useful is siRNAs, also known as
silencing RNAs. These small molecules are usually 20-30 bp long and can be targeted to
a specific mRNA transcripts. Upon base pair-binding to these transcripts, the complex
will be degraded by endogenous cell processes, halting translation of the transcript and
thus production of the protein of interest. Previous studies have already used this
method to knockdown genes in other bacterial species, such as methicillin-resistant
Staphylococcus aureus, although its use in Listeria appears to be limited to simple
screening methods for genes of interest rather than robust studies of the gene
knockdown themselves (62). However, the fact that siRNA delivery has been confirmed
for Listeria is a promising sign that this method could be viable for a project such as this
one.
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While not as novel, transduction is also another method that could be worth
consideration in this particular species of bacteria as it once again does not require
pore-formation on the surface of the cell wall. Instead, it uses synthesized viral
constructs containing a plasmid to deliver the DNA into the host cell. This could be
useful if a marker for selectivity, such as antibiotic resistance, was needed as the original
plasmids featured in this study could still be used with the addition of some
modifications. Unlike siRNAs, colonies recovered after infection with virus could be
screened by simple plating the bacteria on selective media rather than requiring
additional techniques such as Western blots or rtPCR to test for mRNA or protein
production.
Future research should focus on redoing the experiments presented here with
the appropriate controls in place. Other avenues that could be explored include
improving upon the existing protocol by using other commercially available vectors,
different electroporation parameters, and a variety of electrocompetence methods
alongside the general TargeTron Gene Knockout System protocol, as well as trying new
techniques for DNA delivery entirely. While the results here are discouraging, it is
possible that with the proper changes, a fast, effective, and inexpensive TargeTron
protocol could be devised for this particular bacteria. These changes should be explored
in order to gain a better understanding of this system and its potential to become a
possible transformation system for Listeria.
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